Senior Vice President and General Manager of Infectious Disease
Shionogi Inc.
Summary
The Senior Vice President and General Manager will provide the overarching strategic direction for the Infectious Disease business unit. You will be responsible for managing the performance of the business and the overall P&L of a growing portfolio, overseeing the late-stage development and commercialization of antivirals, antibacterials, and antifungals. This role specifically requires a leader who understands hospital (inpatient), long-term care, primary care/retail pharmacy (outpatient) healthcare, and government channels.
Job description
Overview
The Senior Vice President and General Manager will provide the overarching strategic direction for the Infectious Disease business unit. You will be responsible for managing the performance of the business and the overall P&L of a growing portfolio, overseeing the late-stage development and commercialization of antivirals, antibacterials, and antifungals. This role specifically requires a leader who understands hospital (inpatient), long-term care, primary care/retail pharmacy (outpatient) healthcare, and government channels.
Responsibilities
- Direct the strategic direction, profitability, and expansion of the infectious disease business unit and become an active member of the US Commercial Leadership Team
- Set the long-term vision for the business; develop and execute long-term business strategies, including product launch plans, market analysis, and resource allocation to drive growth
- Lead dedicated sales and marketing teams to meet performance and growth targets as well as managing expenses and driving highest impact ROI
- Accountable for the BU's profit and loss, sales volume, margin targets, and financial forecasting
- Define the targets and promotional strategies for both HCPs and Consumers (DTC), and optimize digital tools to enhance brand positioning
- Build relationships with Key Opinion Leaders (KOLs), Professional Associations, and Patient Advocacy Groups, as appropriate
- Partner with New Product Planning, R&D, and Business Development in Phase III or other acquired assets to steer cross-functional prelaunch planning activities and commercialization plans; collaborate with R&D, Medical Affairs, and Market Access to shape the late-stage product pipeline and lifecycle management strategies
- Cross-functionally lead a matrixed and integrated team including Medical Affairs, Market Access, Commercial Operations, Regulatory, Legal, etc. Foster a culture of collaboration and rapid response given the volatile nature of infectious outbreaks
- Partner with global functions including Global Commercial/New Product Planning, Global Medical, and Global Market Access to advance real world evidence, LCM, and other growth opportunities for the US business
- Collaborate with Government Affairs and US Market Access to identify and oversee growth opportunities in the government channel
- Recruit, coach, and retain high-performing, diverse teams, fostering a culture of accountability
- Ensure all activities comply with industry regulations, healthcare laws, and corporate policies
Minimum Job Requirements
- 20+ years in the pharmaceutical industry, with at least 7 years in executive leadership and significant experience in managing cross-functional teams in sales, marketing, and commercial operations
- Existing and current relationships with KOLs in infectious disease is ideal
- Documented history of driving business performance and growth through successful management of existing business and new product launches
- Demonstrated strength in harnessing the power of AI to advance the capabilities of the organization and enable optimal customer-facing interactions
- Bachelor's degree required; MBA or advanced degree (e.g., PharmD) is preferred
- Strong analytical capabilities, leadership, strategic thinking, and P&L experience
- A history of leading teams through high-pressure scenarios (e.g., product recalls, sudden regulatory shifts, or public health emergencies)
- Must live a commutable distance to our US Corporate Headquarters in Florham Park, NJ. Office presence required at least 3 days per week. Travel expectations up to 30% or higher
Requirements
- 20+ years in the pharmaceutical industry
- At least 7 years in executive leadership
- Significant experience managing cross-functional teams in sales, marketing, and commercial operations
- Existing and current relationships with KOLs in infectious disease is ideal
- Documented history of driving business performance and growth through successful management of existing business and new product launches
- Demonstrated strength in harnessing the power of AI to advance organizational capabilities and enable optimal customer-facing interactions
- Bachelor's degree required
- MBA or advanced degree (e.g., PharmD) preferred
- Strong analytical capabilities, leadership, strategic thinking, and P&L experience
- History of leading teams through high-pressure scenarios (e.g., product recalls, sudden regulatory shifts, or public health emergencies)
- Must live a commutable distance to US Corporate Headquarters in Florham Park, NJ
- Office presence required at least 3 days per week
- Travel expectations up to 30% or higher
Benefits
- Comprehensive Benefits
- Bonus
- Long-Term Incentive
- Allowances
Company overview
Shionogi Inc. is a leading Japanese pharmaceutical company with a rich history dating back to 1878. As the U.S. subsidiary of Shionogi & Co., Ltd., the company operates from its headquarters in Florham Park, New Jersey, with a workforce of 501-1,000 employees. Shionogi specializes in research, development, manufacturing, and distribution of pharmaceuticals, diagnostic reagents, and medical devices. The company is particularly renowned for its expertise in antimicrobial resistance and has been at the forefront of developing novel antibiotics since the 1950s. Beyond antibiotics, Shionogi has expanded its portfolio to include innovative medications for HIV, influenza, and COVID-19, while also advancing clinical programs in areas such as Fragile X syndrome, acute ischemic stroke, metabolic disorders, and oncology. The company maintains a strong commitment to addressing global health challenges through strategic partnerships with industry, government agencies, biotech companies, and academia. Shionogi's mission focuses on supplying the best possible medicines to protect patient health and well-being, leveraging both in-house discovery capabilities and collaborative approaches to deliver groundbreaking treatments for patients worldwide.